1Akashi Y,Inoh M,Gamo N,et al.Dermatomyositis associated with membranous nephropathy in a 43-year-old female[J].Am J Nephrol,2002,22(4):385
2Miret C,Font J,Molina R,et al.Lack of correlation between tumor markers (CA 125 and SCC) and systemic lupus erythematosus activity[J].Anticancer Res,1998,18(2B):1341
3Sevinc A,Buyukberber S,Sari R,et al.Elevated serum CA-125 levels in patients with nephrotic syndrome-induced ascites[J].Anticancer Res,2000,20(2B):1201
4Xiao WB,Liu YL.Elevation of serum and ascites cancer antigen 125 levels in patients with liver cirrhosis[J].J Gastroenterol Hepatol,2003,18(11):1315
5Mayo Clin Proc.Cancer antigen 125 in patients with chronic liver disease[J].2002,77(6):538
6Mas MR,Comert B,Saglamkaya U,et al.CA-125; a new marker for diagnosis and follow-up of patients with tuberculous peritonitis[J].Dig Liver Dis,2000,32(7):595
7Camci C,Buyukberber S,Tarakcioglu M,et al.The effect of continuous ambulatory peritoneal dialysis on serum CA-125 levels[J].Eur J Gynaecol Oncol,2002,23(5):472
8Migishima F,Jobo T,Hata H,et al.Uterine leiomyoma causing massive ascites and left pleural effusion with elevated CA 125:a case report[J].J Obstet Gynaecol Re,2000,26(4):283
10Shimojo N,Naka K,Nakajima C,et al.The effect of non-insulin-dependent diabetes on serum concentrations of tumor-associated carbohydrate antigens of CA19-9、CA-50 and sialyl SSEA-1 in association with the Lewis blood phenotype[J].Clin Chim Acta,1990,190(3):283
二级参考文献15
1Sevinc A,Buyukberber S,Sari R,et al. Elevated serum CA-125levels in patients with nephrotic syndrome-induced ascites[J].Anticancer Res,2000,20(2B) :1201-1203.
2Yamashita F, Suzuki T, Takeuchi K, et al. Case of minimal change nephrotic syndrome with high levels of CA 125 antigen [J]. Nippon Naika Gakkai Zasshi,1995,10;84(6) :951-953.
3Akashi, Y,Inoh, M,Gamo N,et al. Dermatomyositis associated with embranous nephropathy in a 43-year-old female[J]. Am J Nephrol,2002,22(4) :385-387.
4Miret C, Font J, Molina R, et al. Lack of correlation between tumor markers (CA 125 and SCC) and systemic lupus erythematosus activity[J]. Anticancer Res, 1998,18(2B): 1341-1344.
5Arik N,Adam B,Akpolat T,et al. Serum tumour markers in renal failure[J]. Int Urol Nephrol,1996,28(4):601-603.
6Menzin AW,Kobrin S,Pollak E,et al. The effect of renal func tion on serum levels of CA 125[J]. Gynecol Oncol,1995,58(3):375-377.
7Xiao WB,Liu YL. Elevation of serum and ascites cancer antigen 125 levels in patients with liver cirrhosis[J]. J Gastroenterol Hepatol,2003,18(11) :1315-1316.
8Mayo Clin Proc. Cancer antigen 125 in patients with chronic liver disease[J]. 2002,77 (6): 538 -541.
9Mas MR,Comert B,Saglamkaya U,et al. CA-125;a new marker for diagnosis and follow-up of patients with tuberculous peritonitis[J]. Dig Liver Dis,2000,32(7) :595-597.
10Docci D, Pistocchi E, Turci F, et al. Serum CA19-9 and CA50antigens in hemodialysis patients [J]. Chn Nephrol, 1987; 27(4): 179-181.
